Literature DB >> 9308385

Completeness of case ascertainment in a Scottish regional cancer registry for the year 1992.

D H Brewster1, J Crichton, J C Harvey, G Dawson.   

Abstract

To assess completeness of case ascertainment by the Scottish Cancer Registry for the year 1992, we assembled a collection of databases containing potential registrations (excluding non-melanoma skin tumours and non-invasive neoplasms) from 14 separate sources relating to the population covered by one of the five regional registries. Apparently missed registrations were identified by linkage of these databases to cancer registration records. Their eligibility for registration was determined by reference in medical records, or when these were unavailable, by reference to the local Community Health Index (to establish residency at the time of diagnosis) in conjunction with the text of the original pathology report and/or the original death certificate. Misclassifications of site or incidence year were not regarded as missed cases. Of 517 apparently missed cancer registrations, 66 cases (3.5% of the revised total number of registrations of malignant neoplasms other than non-melanoma skin tumours for the study area in 1992) should have been registered as new independent primary malignant neoplasms, giving an overall estimate of completeness of 96.5%. The fact that so many apparently missed registrations were not eligible for registration illustrates the limitations of passive registration. Ascertainment of cases by the Scottish Cancer Registry appears to be high for most sites and compares favourably to the figures reported by registries outside Scotland.

Entities:  

Mesh:

Year:  1997        PMID: 9308385     DOI: 10.1016/s0033-3506(97)00065-6

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  23 in total

1.  Is detecting oral cancer in general dental practices a realistic expectation? A population-based study using population linked data in Scotland.

Authors:  M Purkayastha; A D McMahon; J Gibson; D I Conway
Journal:  Br Dent J       Date:  2018-08-10       Impact factor: 1.626

2.  Prognostic factors in women with breast cancer: distribution by socioeconomic status and effect on differences in survival.

Authors:  C S Thomson; D J Hole; C J Twelves; D H Brewster; R J Black
Journal:  J Epidemiol Community Health       Date:  2001-05       Impact factor: 3.710

3.  Completeness of case ascertainment at the Irish National Cancer Registry.

Authors:  K O'Brien; H Comber; L Sharp
Journal:  Ir J Med Sci       Date:  2013-08-17       Impact factor: 1.568

4.  Interval cancers in a national colorectal cancer screening programme.

Authors:  Robert Jc Steele; Greig Stanners; Jaroslaw Lang; David H Brewster; Francis A Carey; Callum G Fraser
Journal:  United European Gastroenterol J       Date:  2016-01-06       Impact factor: 4.623

5.  Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study.

Authors:  A Gregor; C S Thomson; D H Brewster; P L Stroner; J Davidson; R J Fergusson; R Milroy
Journal:  Thorax       Date:  2001-03       Impact factor: 9.139

6.  Accuracy of reporting of family history of colorectal cancer.

Authors:  R J Mitchell; D Brewster; H Campbell; M E M Porteous; A H Wyllie; C C Bird; M G Dunlop
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

7.  Evaluation of three algorithms to identify incident breast cancer in Medicare claims data.

Authors:  Heather T Gold; Huong T Do
Journal:  Health Serv Res       Date:  2007-10       Impact factor: 3.402

8.  Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals.

Authors:  Malcolm G Dunlop; Albert Tenesa; Susan M Farrington; Stephane Ballereau; David H Brewster; Thibaud Koessler; Paul Pharoah; Clemens Schafmayer; Jochen Hampe; Henry Völzke; Jenny Chang-Claude; Michael Hoffmeister; Hermann Brenner; Susanna von Holst; Simone Picelli; Annika Lindblom; Mark A Jenkins; John L Hopper; Graham Casey; David Duggan; Polly A Newcomb; Anna Abulí; Xavier Bessa; Clara Ruiz-Ponte; Sergi Castellví-Bel; Iina Niittymäki; Sari Tuupanen; Auli Karhu; Lauri Aaltonen; Brent Zanke; Tom Hudson; Steven Gallinger; Ella Barclay; Lynn Martin; Maggie Gorman; Luis Carvajal-Carmona; Axel Walther; David Kerr; Steven Lubbe; Peter Broderick; Ian Chandler; Alan Pittman; Steven Penegar; Harry Campbell; Ian Tomlinson; Richard S Houlston
Journal:  Gut       Date:  2012-04-05       Impact factor: 23.059

9.  Risk of cancer following primary total hip replacement or primary resurfacing arthroplasty of the hip: a retrospective cohort study in Scotland.

Authors:  D H Brewster; D L Stockton; A Reekie; G P Ashcroft; C R Howie; D E Porter; R J Black
Journal:  Br J Cancer       Date:  2013-04-02       Impact factor: 7.640

10.  Completeness of case ascertainment and survival time error in English cancer registries: impact on 1-year survival estimates.

Authors:  H Møller; S Richards; N Hanchett; S P Riaz; M Lüchtenborg; L Holmberg; D Robinson
Journal:  Br J Cancer       Date:  2011-05-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.